2021
DOI: 10.1038/s41386-021-01002-9
|View full text |Cite
|
Sign up to set email alerts
|

A large-scale genome-wide gene expression analysis in peripheral blood identifies very few differentially expressed genes related to antidepressant treatment and response in patients with major depressive disorder

Abstract: A better understanding of the biological factors underlying antidepressant treatment in patients with major depressive disorder (MDD) is needed. We perform gene expression analyses and explore sources of variability in peripheral blood related to antidepressant treatment and treatment response in patients suffering from recurrent MDD at baseline and after 8 weeks of treatment. The study includes 281 patients, which were randomized to 8 weeks of treatment with vortioxetine (N = 184) or placebo (N = 97). To our … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
6
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 9 publications
(8 citation statements)
references
References 40 publications
(56 reference statements)
2
6
0
Order By: Relevance
“…Investigating gene expression of all participants, visual inspection of the PCA revealed no obvious grouping of samples ( Supplementary Figure S5 ). This is in line with rather subtle gene expression changes that one may expect in blood in the context of mental disorders ( 56 , 57 ). Analyzing DGE using DESeq2 ( 43 ), 13 significantly (FDR-corrected p ≤ 0.1 for multiple correction) differentially expressed genes (DEGs) were identified which had a |l2fc| ≥ 0.3 in SAD condition compared to healthy individuals without SAD ( Figure 1A ; Supplementary Table S4 ), while no significant differences in expression were identified in ELA condition compared to individuals without the experience of ELA ( Supplementary Table S5 ).…”
Section: Resultssupporting
confidence: 70%
“…Investigating gene expression of all participants, visual inspection of the PCA revealed no obvious grouping of samples ( Supplementary Figure S5 ). This is in line with rather subtle gene expression changes that one may expect in blood in the context of mental disorders ( 56 , 57 ). Analyzing DGE using DESeq2 ( 43 ), 13 significantly (FDR-corrected p ≤ 0.1 for multiple correction) differentially expressed genes (DEGs) were identified which had a |l2fc| ≥ 0.3 in SAD condition compared to healthy individuals without SAD ( Figure 1A ; Supplementary Table S4 ), while no significant differences in expression were identified in ELA condition compared to individuals without the experience of ELA ( Supplementary Table S5 ).…”
Section: Resultssupporting
confidence: 70%
“…Investigating gene expression of all participants, visual inspection of the PCA revealed no obvious grouping of samples (Fig S5). This is in line with rather subtle gene expression changes that one may expect in blood in the context of mental disorders [51,52]. Analyzing differential gene expression using DESeq2 [39], 13 significantly (FDR-corrected p ≤ 0.1) differentially expressed genes (DEGs) were identified which had a |l2fc| ≥ 0.3 with respect to SAD (Fig.…”
Section: Differential Gene Expression With Respect To Sad But Not Elasupporting
confidence: 62%
“…This study did include multiple limitations that should be addressed to better understand antidepressant effectiveness. Only two studies provided gene expression data for responders and non-responders prior to treatment, so it is not possible to derive strong inferences for predictive markers of fluoxetine response; even large-scale patient studies have struggled to identify general predictive markers to this point(18,97). Only two patient cohorts were included in our meta-analyses: while other studies have been conducted in patients, they tend to focus on a small number of biomarkers or otherwise do not submit full expression data to GEO(18).…”
Section: Discussionmentioning
confidence: 99%